Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Apyx Medical Corp    APYX

APYX MEDICAL CORP

(APYX)
  Report
 SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2020 17,1 M - -
Net income 2020 -23,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -6,96x
Yield 2020 -
Sales 2021 34,1 M - -
Net income 2021 -23,8 M - -
Net cash position 2021 51,4  - -
P/E ratio 2021 -7,32x
Yield 2021 -
Capitalization 158 M 158 M -
Capi. / Sales 2020 9,19x
EV / Sales 2021 3,11x
Nbr of Employees 266
Free-Float 87,6%
More Financials
Company
Apyx Medical Corporation, formerly Bovie Medical Corporation, is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through two segments: OEM and J-Plasma. It is engaged in... 
More about the company
Surperformance© ratings of Apyx Medical Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on APYX MEDICAL CORP
06/25APYX MEDICAL CORPORATION : to Release Second Quarter of Fiscal Year 2020 Financi..
BU
06/22APYX MEDICAL CORPORATION : Announces Regulatory Clearance to Market and Sell its..
BU
06/06KASKELA LAW LLC : Announces Investigation of Apyx Medical Corp. (APYX) and Encou..
PR
05/29APYX MEDICAL : ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Continues to Investi..
PR
05/23KASKELA LAW LLC : Announces Stockholder Investigation of Apyx Medical Corp. (APY..
BU
05/18Apyx Medical Corporation Officers and Directors Under Investigation by Schube..
PR
05/11APYX MEDICAL : Management's Discussion and Analysis of Financial Condition and R..
AQ
05/11APYX : 1Q Earnings Snapshot
AQ
05/11APYX MEDICAL CORP : Results of Operations and Financial Condition, Financial Sta..
AQ
05/11APYX MEDICAL CORPORATION : Reports First Quarter 2020 Financial Results
BU
04/17APYX MEDICAL INVESTIGATION INITIATED : Kahn Swick & Foti, LLC Investigates the O..
BU
04/12APYX LOSS NOTICE : ROSEN, A TOP FIRM, Continues to Investigate Securities Claims..
BU
04/12Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apyx Medical..
PR
04/07APYX MEDICAL CORPORATION : to Release First Quarter of Fiscal Year 2020 Financia..
BU
03/31APYX MEDICAL : Management's Discussion and Analysis of Financial Condition and R..
AQ
More news
News in other languages on APYX MEDICAL CORP
06/25APYX MEDICAL CORPORATION : to Release Second Quarter of Fiscal Year 2020 Financi..
06/22APYX MEDICAL CORPORATION : Announces Regulatory Clearance to Market and Sell its..
06/06KASKELA LAW LLC : Announces Investigation of Apyx Medical Corp. (APYX) and Encou..
05/29APYX MEDICAL : ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Continues to Investi..
05/23KASKELA LAW LLC : Announces Stockholder Investigation of Apyx Medical Corp. (APY..
More news
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 7,75 $
Last Close Price 4,61 $
Spread / Highest target 139%
Spread / Average Target 68,1%
Spread / Lowest Target 8,46%
EPS Revisions
Managers
NameTitle
Charles D. Goodwin President, Chief Executive Officer & Director
Andrew Makrides Executive Chairman
Tara H. Semb Chief Financial Officer, Secretary & Treasurer
Shawn D. Roman Director-Research & Development
Kari Larson Senior Director-Clinical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
APYX MEDICAL CORP0.00%158
MEDTRONIC PLC-20.56%122 876
BAXTER INTERNATIONAL INC.2.48%42 834
DEXCOM, INC.101.38%40 180
HOYA CORPORATION4.40%37 414
TERUMO CORPORATION2.91%28 152